相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
Anna S. Berghoff et al.
NATURE REVIEWS NEUROLOGY (2019)
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+signature
Friedrich Erhart et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
Chia-Ing Jan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
Friedrich Erhart et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
Johanna Buchroithner et al.
CANCERS (2018)
miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal
Ana Clara P. Azevedo-Pouly et al.
FUNCTIONAL & INTEGRATIVE GENOMICS (2017)
Advances in immunotherapy for the treatment of glioblastoma
Amanda Tivnan et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition
Eric W. Deutsch et al.
NUCLEIC ACIDS RESEARCH (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Bacterial Cellulose Shifts Transcriptome and Proteome of Cultured Endothelial Cells Towards Native Differentiation
Gerhard Feil et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE 143
D. A. Reardona et al.
NEURO-ONCOLOGY (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity
Gregory Riddick et al.
SCIENTIFIC REPORTS (2017)
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
J. C. Soria et al.
ANNALS OF ONCOLOGY (2016)
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Ulrich Herrlinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
Ignacio Sancho-Martinez et al.
NATURE COMMUNICATIONS (2016)
Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation
Hannah J. Anderson et al.
CELLULAR ONCOLOGY (2016)
Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation
Sylvia Weilner et al.
BONE (2015)
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
David L. Schonberg et al.
CANCER CELL (2015)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
Brain tumour cells interconnect to a functional and resistant network
Matthias Osswald et al.
NATURE (2015)
Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro
Katja Storch et al.
ONCOLOGY REPORTS (2015)
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors
Barbara Fazi et al.
ONCOTARGET (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
The diverse roles and multiple forms of focal adhesion kinase in brain
Beatriz G. Armendariz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Targeting FAK in human cancer: from finding to first clinical trials
Vita M. Golubovskaya
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
Acquired and intrinsic resistance in cancer immunotherapy
Sander Kelderman et al.
MOLECULAR ONCOLOGY (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Surprisal Analysis of Glioblastoma Multiform (GBM) MicroRNA Dynamics Unveils Tumor Specific Phenotype
Sohila Zadran et al.
PLOS ONE (2014)
Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
Richard G. Everson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
TGF-β as a therapeutic target in high grade gliomas - Promises and challenges
Justin V. Joseph et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Pharmacologic Blockade of FAK Autophosphorylation Decreases Human Glioblastoma Tumor Growth and Synergizes with Temozolomide
Vita M. Golubovskaya et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition
Maya Srikanth et al.
NEURO-ONCOLOGY (2013)
Transcriptional Profiling of Human Dendritic Cell Populations and Models - Unique Profiles of In Vitro Dendritic Cells and Implications on Functionality and Applicability
Kristina Lundberg et al.
PLOS ONE (2013)
A Novel Zebrafish Xenotransplantation Model for Study of Glioma Stem Cell Invasion
Xiao-jun Yang et al.
PLOS ONE (2013)
1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data
Juergen Cox et al.
BMC BIOINFORMATICS (2012)
Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
Hua Mao et al.
CANCER INVESTIGATION (2012)
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival
V. Goidts et al.
ONCOGENE (2012)
miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR
Dario de Biase et al.
PLOS ONE (2012)
Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells
S. Chakraborty et al.
BRITISH JOURNAL OF CANCER (2011)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
Min Deng et al.
JOURNAL OF CELL SCIENCE (2011)
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido et al.
CANCER CELL (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Benito Campos et al.
CLINICAL CANCER RESEARCH (2010)
Got target?: computational methods for microRNA target prediction and their extension
Hyeyoung Min et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Gliomas display a microRNA expression profile reminiscent of neural precursor cells
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Physiological and pathological roles for microRNAs in the immune system
Ryan M. O'Connell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
PPARγ agonists inhibit growth and expansion of CD133+brain tumour stem cells
W. Chearwae et al.
BRITISH JOURNAL OF CANCER (2008)
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Christopher J. Wheeler et al.
CANCER RESEARCH (2008)
A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth
Vita M. Golubovskaya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Expression of MHC I and NK ligands on human CD133(+) glioma cells: possible targets of immunotherapy
Anhua Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Serena Pellegatta et al.
CANCER RESEARCH (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Medical progress: Brain tumors
LM DeAngelis
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
